Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks

Ann Allergy Asthma Immunol. 2009 Nov;103(5):448. doi: 10.1016/S1081-1206(10)60369-9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / therapeutic use*
  • Adult
  • Bradykinin / administration & dosage
  • Bradykinin / analogs & derivatives*
  • Bradykinin / therapeutic use
  • Bradykinin Receptor Antagonists*
  • Complement C1 Inhibitor Protein / genetics
  • Female
  • Gene Deletion
  • Hereditary Angioedema Type III / drug therapy*
  • Hereditary Angioedema Type III / genetics
  • Humans
  • Injections, Subcutaneous
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists
  • Bradykinin Receptor Antagonists
  • Complement C1 Inhibitor Protein
  • icatibant
  • Bradykinin